Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value (MIST)
CUSIP: 59935V107
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 11,824,370
- Total 13F value
- $9,461,152
- Share change
- -12,723,000
- Put/Call ratio
- 21%
- SEC-reported price per share
- $0.80
- Number of holders
- 43
- Value change
- -$26,033,743
- Number of buys
- 20
- Number of sells
- 26
- Shares outstanding
- 124,217,096
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
43
Top holders
10
MIST full security history
Ownership snapshot
Full 13F holder table
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTEGRATED CORE STRATEGIE...
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 0.6%
13D/G row: INTEGRATED CORE STRATEGIES (US) LLC
Showing 1-6 of 15 holder rows.
Quick read
INTEGRATED CORE STRATEGIES (US) LLC leads the comparable SEC ownership view at 0.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTEGRATED CORE STRATEGIES (US) LLC's linked filing trail.
Comparable ownership
Top 5
INTEGRATED CORE STRATEGIES (US) LLC
0.6%
BlackRock, Inc.
3.3%
MILLENNIUM MANAGEMENT LLC
2.2%
Alta Fundamental Advisers LLC
2.1%
RTW INVESTMENTS, LP
2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
0.6%
|
$396,161
322,082 shares
|
$0 | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
3.3%
|
$9,559,619
4,050,686 shares
|
— | 31 Dec 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
2.2%
|
$6,379,691
2,703,259 shares
|
— | 31 Dec 2024 |
| Alta Fundamental Advisers LLC |
13F
Company
|
2.1%
|
$6,274,270
2,658,589 shares
|
— | 31 Dec 2024 |
| RTW INVESTMENTS, LP |
3/4/5
13F
10%+ Owner · Company
|
2%
from 13F
|
$28,360,648
3,256,102 shares
|
— | 22 Mar 2023 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.6%
|
$4,720,000
2,000,000 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
11,824,370
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
43
Q1 2025 holders
43
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|